 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 June 1993 | Volume 118 Issue 12 | Pages 956-963
Purpose: To evaluate the possibility that fibrinogen represents a cardiovascular risk factor.
Data Identification: A computerized literature search (1980 to 1992) identified all published epidemiologic studies on fibrinogen and cardiovascular disease. Clinical and basic research data were found by separate searches. References of all papers thus obtained were studied and relevant papers included.
Study Selection: Six prospective epidemiologic studies were included in a meta-analysis (one study was excluded because the study population was nonrepresentative). Clinical papers were reviewed separately for other evidence of causation.
Data Extraction: The correlation of fibrinogen levels on the subsequent incidence of myocardial infarction, stroke, and peripheral arterial occlusive disease was assessed and the causality of the association was analyzed. Calculations were made to examine fibrinogen level (in tertiles) versus cardiovascular risk. Odds ratios of high versus low tertile were computed.
Results of Data Analysis: All prospective studies showed that fibrinogen was associated with subsequent myocardial infarction or stroke. A total of 92 147 person-years was covered by these investigations. Odds ratios varied between 1.8 (95% CI, 1.2 to 2.5) in the Framingham and 4.1 (CI, 2.3 to 6.9) in the GRIPS study, with a summary odds ratio of 2.3 (CI, 1.9 to 2.8). Associations existed between fibrinogen and other cardiovascular risk factors, but after multivariate analysis, only the association between fibrinogen and cardiovascular events remained. The majority of the preconditions for causality were fulfilled, indicating that fibrinogen is pathophysiologically related to cardiovascular events.
Conclusions: Fibrinogen can be considered a major cardiovascular risk factor. Future studies of cardiovascular morbidity and death should include this variable.
Author and Article Information
From the University of Vienna, Austria.
REVIEW
Fibrinogen as a Cardiovascular Risk Factor
A Meta-Analysis and Review of the Literature
This article has been cited by other articles:
|
|
 |
|
  N. Ochs, R. Auer, D. C. Bauer, D. Nanchen, J. Gussekloo, J. Cornuz, and N. Rodondi Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality Ann Intern Med, June 3, 2008; 148(11): 832 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Koch, P. Hoppmann, J. Biele, J. C. Mueller, A. Schomig, and A. Kastrati Fibrinogen Genes and Myocardial Infarction: A Haplotype Analysis Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 758 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Associations of Plasma Fibrinogen Levels with Established Cardiovascular Disease Risk Factors, Inflammatory Markers, and Other Characteristics: Individual Participant Meta-Analysis of 154,211 Adults in 31 Prospective Studies: The Fibrinogen Studies Collaboration Am. J. Epidemiol., October 15, 2007; 166(8): 867 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Parolari, M. Camera, F. Alamanni, M. Naliato, G. L. Polvani, M. Agrifoglio, M. Brambilla, C. Biancardi, L. Mussoni, P. Biglioli, et al. Systemic Inflammation After On-Pump and Off-Pump Coronary Bypass Surgery: A One-Month Follow-Up Ann. Thorac. Surg., September 1, 2007; 84(3): 823 - 828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Jenny, N. D. Yanez, B. M. Psaty, L. H. Kuller, C. H. Hirsch, and R. P. Tracy Inflammation Biomarkers and Near-Term Death in Older Men Am. J. Epidemiol., March 15, 2007; 165(6): 684 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Ganotakis, I. F. Gazi, J. A. Papadakis, I. A. Jagroop, D. R. Nair, and D. P. Mikhailidis The Relationship Between Circulating Fibrinogen and Lipoprotein (a) Levels in Patients With Primary Dyslipidemia Clinical and Applied Thrombosis/Hemostasis, January 1, 2007; 13(1): 35 - 42. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Thyagarajan, D. R Jacobs, G. G Apostol, L. J Smith, C. E Lewis, and O D. Williams Plasma fibrinogen and lung function: the CARDIA Study Int. J. Epidemiol., August 1, 2006; 35(4): 1001 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Circulation, June 20, 2006; 113(24): e873 - e923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-W. Song, H.-S. Lee, M. S. Kim, J. M. Lee, J. H. Kim, B.-H. Nam, and J. I. Zo Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection Ann. Thorac. Surg., June 1, 2006; 81(6): 1974 - 1981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Stroke, June 1, 2006; 37(6): 1583 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Iwaki, M. J. Sandoval-Cooper, M. Brechmann, V. A. Ploplis, and F. J. Castellino A fibrinogen deficiency accelerates the initiation of LDL cholesterol-driven atherosclerosis via thrombin generation and platelet activation in genetically predisposed mice Blood, May 15, 2006; 107(10): 3883 - 3891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ziakas, S. Gavrilidis, G. Giannoglou, E. Souliou, K. Gemitzis, D. Kalampalika, M. A. Vayona, I. Pidonia, G. Parharidis, and G. Louridas In-Hospital and Long-Term Prognostic Value of Fibrinogen, CRP, and IL-6 Levels in Patients with Acute Myocardial Infarction Treated with Thrombolysis Angiology, May 1, 2006; 57(3): 283 - 293. [Abstract] [PDF]
|
|
|
|
|
|
R. L. Sacco, R. Adams, G. Albers, M. J. Alberts, O. Benavente, K. Furie, L. B. Goldstein, P. Gorelick, J. Halperin, R. Harbaugh, et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Circulation, March 14, 2006; 113(10): e409 - e449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Sacco, R. Adams, G. Albers, M. J. Alberts, O. Benavente, K. Furie, L. B. Goldstein, P. Gorelick, J. Halperin, R. Harbaugh, et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke, February 1, 2006; 37(2): 577 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. van Oijen, J. C. Witteman, A. Hofman, P. J. Koudstaal, and M. M.B. Breteler Fibrinogen Is Associated With an Increased Risk of Alzheimer Disease and Vascular Dementia Stroke, December 1, 2005; 36(12): 2637 - 2641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Fibrinogen Studies Collaboration* Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality: An Individual Participant Meta-analysis JAMA, October 12, 2005; 294(14): 1799 - 1809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Demir, M. Soylu, O. Ozdemir, S. Topaloglu, D. Aras, A. Iasmaz, and I. Korkmaz Do Different Atrial Flutter Types Carry the Same Thromboembolic Risk? Angiology, September 1, 2005; 56(5): 593 - 599. [Abstract] [PDF]
|
|
|
|
|
|
J. M. Soria, L. Almasy, J. C. Souto, A. Buil, M. Lathrop, J. Blangero, and J. Fontcuberta A Genome Search for Genetic Determinants That Influence Plasma Fibrinogen Levels Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1287 - 1292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Papadakis, D. P. Mikhailidis, G. E. Vrentzos, A. Kalikaki, I. Kazakou, and E. S. Ganotakis Effect of Antihypertensive Treatment on PlasmaFibrinogen and Serum HDL Levelsin Patients with Essential Hypertension Clinical and Applied Thrombosis/Hemostasis, April 1, 2005; 11(2): 139 - 146. [Abstract] [PDF]
|
|
|
|
 |
|
 L. RETTERSTOL, K. E. BERGE, O. BRAATEN, L. EIKVAR, T. R. PEDERSEN, and L. SANDVIK A DAILY GLASS OF RED WINE: DOES IT AFFECT MARKERS OF INFLAMMATION? Alcohol Alcohol., March 1, 2005; 40(2): 102 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M P J van Goor, E B Gomez-Garcia, F W G Leebeek, G J Brouwers, P J Koudstaal, and D W J Dippel The - 148 C/T fibrinogen gene polymorphism and fibrinogen levels in ischaemic stroke: a case-control study J. Neurol. Neurosurg. Psychiatry, January 1, 2005; 76(1): 121 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W.F. Wilson CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Ability of Inflammatory Markers to Predict Disease in Asymptomatic Patients: A Background Paper Circulation, December 21, 2004; 110(25): e568 - e571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Rothwell, S. C. Howard, D. A. Power, S. A. Gutnikov, A. Algra, J. van Gijn, T. G. Clark, M. F.G. Murphy, C. P. Warlow, and for the Cerebrovascular Cohort Studies Collaborati Fibrinogen Concentration and Risk of Ischemic Stroke and Acute Coronary Events in 5113 Patients With Transient Ischemic Attack and Minor Ischemic Stroke Stroke, October 1, 2004; 35(10): 2300 - 2305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Horne III, K. K. Singh, K. G. Rosenfeld, R. Wesley, M. C. Skarulis, P. K. Merryman, A. Cullinane, R. Costello, A. Patterson, T. Eggerman, et al. Is Thyroid Hormone Suppression Therapy Prothrombotic? J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4469 - 4473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Scott, R. A.S. Ariens, and P. J. Grant Genetic and Environmental Determinants of Fibrin Structure and Function: Relevance to Clinical Disease Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1558 - 1566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Atkinson, W. Oosthuizen, S. Scollen, A. Loktionov, N. E. Day, and S. A. Bingham Modest Protective Effects of Isoflavones from a Red Clover-Derived Dietary Supplement on Cardiovascular Disease Risk Factors in Perimenopausal Women, and Evidence of an Interaction with ApoE Genotype in 49-65 Year-Old Women J. Nutr., July 1, 2004; 134(7): 1759 - 1764. [Abstract] [Full Text]
|
|
|
|
 |
|
 J.W.G Yarnell, C.C Patterson, P.M Sweetnam, and G.D.O Lowe Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies Eur. Heart J., June 2, 2004; 25(12): 1049 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Aso, K.-i. Okumura, T. Inoue, R. Matsutomo, N. Yoshida, S. Wakabayashi, K. Takebayashi, and T. Inukai Results of Blood Inflammatory Markers Are Associated More Strongly With Toe-Brachial Index Than With Ankle-Brachial Index in Patients With Type 2 Diabetes Diabetes Care, June 1, 2004; 27(6): 1381 - 1386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.P. Collet, C. Nagaswami, D.H. Farrell, G. Montalescot, and J.W. Weisel Influence of {gamma}' Fibrinogen Splice Variant on Fibrin Physical Properties and Fibrinolysis Rate Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 382 - 386. [Abstract] [Full Text]
|
|
|
|
|
|
P. Muntner, L. L. Hamm, J. W. Kusek, J. Chen, P. K. Whelton, and J. He The Prevalence of Nontraditional Risk Factors for Coronary Heart Disease in Patients with Chronic Kidney Disease Ann Intern Med, January 6, 2004; 140(1): 9 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Lee and G. Y. H. Lip Effects of Lifestyle on Hemostasis, Fibrinolysis, and Platelet Reactivity: A Systematic Review Arch Intern Med, October 27, 2003; 163(19): 2368 - 2392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kamath and G.Y.H. Lip Fibrinogen: biochemistry, epidemiology and determinants QJM, October 1, 2003; 96(10): 711 - 729. [Full Text] [PDF]
|
|
|
|
 |
|
 P Jousilahti, V Salomaa, V Rasi, E Vahtera, and T Palosuo Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status J. Epidemiol. Community Health, September 1, 2003; 57(9): 730 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Tousoulis, G Davies, C Stefanadis, P Toutouzas, and J A Ambrose Inflammatory and thrombotic mechanisms in coronary atherosclerosis Heart, September 1, 2003; 89(9): 993 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schattner and M. H. Liang The Cardiovascular Burden of Lupus: A Complex Challenge Arch Intern Med, July 14, 2003; 163(13): 1507 - 1510. [Full Text] [PDF]
|
|
|
|
|
|
P. De Pablo, A. Ramirez, E. Cortina, A. D. l. Pena, J. Zamora, R. Izaguirre, and M.-C. Amigo Increased Fibrin Polymerization Rate in Patients with Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus Clinical and Applied Thrombosis/Hemostasis, July 1, 2003; 9(3): 221 - 225. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Kang, K. Chu, D.-E. Kim, S.-W. Jeong, J.-W. Lee, and J.-K. Roh POEMS Syndrome Associated With Ischemic Stroke Arch Neurol, May 1, 2003; 60(5): 745 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Klein, S. J. Hunter, A. J. Jenkins, D. Zheng, A. J. Semler, J. Clore, W. T. Garvey, and The DCCT/EDIC Study Group Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care, May 1, 2003; 26(5): 1439 - 1448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Kitas and N. Erb Tackling ischaemic heart disease in rheumatoid arthritis Rheumatology, May 1, 2003; 42(5): 607 - 613. [Full Text] [PDF]
|
|
|
|
|
|
M. Martiskainen, T. Pohjasvaara, J. Mikkelsson, R. Mantyla, T. Kunnas, P. Laippala, E. Ilveskoski, M. Kaste, P.J. Karhunen, and T. Erkinjuntti Fibrinogen Gene Promoter -455 A Allele as a Risk Factor for Lacunar Stroke Stroke, April 1, 2003; 34(4): 886 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Shlipak, L. F. Fried, C. Crump, A. J. Bleyer, T. A. Manolio, R. P. Tracy, C. D. Furberg, and B. M. Psaty Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency Circulation, January 7, 2003; 107(1): 87 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Gulledge, C. McShea, T. Schwartz, G. Koch, and S. T. Lord Effects of Hyperfibrinogenemia on Vasculature of C57BL/6 Mice With and Without Atherogenic Diet Arterioscler. Thromb. Vasc. Biol., January 1, 2003; 23(1): 130 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tonstad, K. Smerud, and L. Hoie A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects Am. J. Clinical Nutrition, July 1, 2002; 76(1): 78 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lochow, A. Schwartzbard, J. Guest, C. Ripps, D. Matalon, R. Gambetta, P. A. Tunick, and S. Sedlis Elevated Prothrombin and Activated Protein C Resistance in Patients with Thoracic Aortic Atheroma Angiology, July 1, 2002; 53(4): 423 - 428. [Abstract] [PDF]
|
|
|
|
|
|
M. Acevedo, G. L. Pearce, K. Kottke-Marchant, and D. L. Sprecher Elevated Fibrinogen and Homocysteine Levels Enhance the Risk of Mortality in Patients From a High-Risk Preventive Cardiology Clinic Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 1042 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Braunstein, D. W. Kershner, P. Bray, G. Gerstenblith, S. P. Schulman, W. S. Post, and R. S. Blumenthal Interaction of Hemostatic Genetics With Hormone Therapy : New Insights To Explain Arterial Thrombosis in Postmenopausal Women Chest, March 1, 2002; 121(3): 906 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E Roeters van Lennep, H.T. Westerveld, D.W. Erkelens, and E. E van der Wall Risk factors for coronary heart disease: implications of gender Cardiovasc Res, February 15, 2002; 53(3): 538 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Wahid, S. M. Marshall, and T. H. Thomas Increased Platelet and Erythrocyte External Cell Membrane Phosphatidylserine in Type 1 Diabetes and Microalbuminuria Diabetes Care, November 1, 2001; 24(11): 2001 - 2003. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Palmieri, A. Celentano, M. J. Roman, G. de Simone, M. R. Lewis, L. Best, E. T. Lee, D. C. Robbins, B. V. Howard, and R. B. Devereux Fibrinogen and Preclinical Echocardiographic Target Organ Damage: The Strong Heart Study Hypertension, November 1, 2001; 38(5): 1068 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Iacoviello, M. Vischetti, F. Zito, and M. Benedetta Donati Genes Encoding Fibrinogen and Cardiovascular Risk Hypertension, November 1, 2001; 38(5): 1199 - 1203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Milionis, E. Rizos, and D. P. Mikhailidis Smoking Diminishes the Beneficial Effect of Statins: Observations from the Landmark Trials Angiology, September 1, 2001; 52(9): 575 - 587. [Abstract] [PDF]
|
|
|
|
|
|
A. I. Vinik, T. Erbas, T. S. Park, R. Nolan, and G. L. Pittenger Platelet Dysfunction in Type 2 Diabetes Diabetes Care, August 1, 2001; 24(8): 1476 - 1485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. REDMAN and H. XIA Fibrinogen Biosynthesis: Assembly, Intracellular Degradation, and Association with Lipid Synthesis and Secretion Ann. N.Y. Acad. Sci., June 1, 2001; 936(1): 480 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yano, J. S. Grove, R. Chen, B. L. Rodriguez, J. D. Curb, and R. P. Tracy Plasma Fibrinogen as a Predictor of Total and Cause-Specific Mortality in Elderly Japanese-American Men Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 1065 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Williams and P. F. Bray Genetics of Arterial Prothrombotic Risk States Experimental Biology and Medicine, May 1, 2001; 226(5): 409 - 419. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Padwal, S. E Straus, and F. A McAlister Evidence based management of hypertension: Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review BMJ, April 21, 2001; 322(7292): 977 - 980. [Full Text]
|
|
|
|
|
|
P. Lind, B. Hedblad, L. Stavenow, L. Janzon, K. F. Eriksson, and F. Lindgarde Influence of Plasma Fibrinogen Levels on the Incidence of Myocardial Infarction and Death Is Modified by Other Inflammation-Sensitive Proteins : A Long-Term Cohort Study Arterioscler. Thromb. Vasc. Biol., March 1, 2001; 21(3): 452 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Tegos, E. Kalodiki, M. M. Sabetai, and A. N. Nicolaides The Genesis of Atherosclerosis and Risk Factors: A Review Angiology, February 1, 2001; 52(2): 89 - 98. [Abstract] [PDF]
|
|
|
|
|
Article
